COMMUNIQUÉS West-GlobeNewswire

March Biosciences Receives FDA Orphan Drug Designation for MB-105, a First-in-Class CD5 CAR-T Cell Therapy, for T-Cell Lymphoma
28/01/2025
Company prepares to advance to Phase 2 clinical trial in early 2025 HOUSTON, Jan. 28, 2025 (GLOBE NEWSWIRE) -- March Biosciences (March Bio), an emerging clinical stage biotechnology company committed to combating [...]
Lighthouse Autism Center Announces New Location in South Sioux City, Nebraska, creating 35 Jobs and Serving 25 Families
28/01/2025
Leading ABA Provider Set to Open Newest Location in South Sioux City, NE SOUTH SIOUX CITY, Neb., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Lighthouse Autism Center, South Sioux City, Nebraska, a leading provider of center-based [...]
Zenas BioPharma to Present at the Guggenheim SMID Cap Biotech Conference
28/01/2025
WALTHAM, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and [...]
Totus Medicines Appoints Simon Harnest, MSc, BSc, as Chief Financial Officer
28/01/2025
Appoints Simon Harnest as Chief Financial Officer to advance capital markets and corporate development strategy supporting TOS-358, the Company’s lead covalent PI3Kα inhibitor, and additional programs EMERYVILLE, Calif [...]
LifeMD to Participate in the 12th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
28/01/2025
NEW YORK, Jan. 28, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the 12 th Annual BTIG MedTech, Digital Health, Life [...]
Telix Completes Acquisition of RLS (USA) Inc.
27/01/2025
MELBOURNE, Australia and INDIANAPOLIS, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces it has completed the acquisition of RLS (USA) Inc. (RLS [...]
Dentsply Sirona to Host Fourth Quarter and Full Year 2024 Conference Call on February 27th
27/01/2025
CHARLOTTE, N.C., Jan. 27, 2025 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) today announced that the Company will be hosting an investor conference call and live webcast [...]
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
27/01/2025
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of [...]
89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
27/01/2025
SAN FRANCISCO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- 89bio, Inc. (“89bio”) (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the [...]
IMAC Holdings Introduces Ignite Proteomics: A New Standard for Matching Patients with the Right Cancer Therapies
27/01/2025
Nashville, TN, Jan. 27, 2025 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: BACK) (“IMAC Holdings” or the “Company”) has launched Ignite Proteomics LLC (“Ignite”), its new subsidiary dedicated to helping doctors [...]
Beyond Air® Schedules Third Fiscal Quarter 2025 Financial Results Conference Call and Webcast
27/01/2025
GARDEN CITY, N.Y., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Medexus Pharmaceuticals Announces Overnight Marketed Public Offering of Common Shares
27/01/2025
NOT FOR DISTRIBUTION TO UNITED STATES TORONTO and CHICAGO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- Medexus Pharmaceuticals Inc. (“Medexus” or the “Company”) (TSX: MDP), is pleased to announce that it has launched an overnight [...]
Akero Therapeutics Announces Proposed Public Offering of Common Stock
27/01/2025
SOUTH SAN FRANCISCO, Calif., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational treatments for patients with serious metabolic disease marked [...]
Apellis Receives Approval of SYFOVRE® (pegcetacoplan) in Australia for Geographic Atrophy (GA)
27/01/2025
WALTHAM, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) announced today that the Therapeutic Goods Administration (TGA) has approved SYFOVRE ® (pegcetacoplan) for the every-other- [...]
American Nurses Foundation Appoints New Executive Director
27/01/2025
Graig R. Eastin was selected as executive director SILVER SPRING, MD, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The American Nurses Foundation (the foundation), the philanthropic arm of the American Nurses Association today [...]
LeMaitre Will Announce Fourth Quarter 2024 Earnings Results February 27, 2025
27/01/2025
BURLINGTON, Mass., Jan. 27, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its fourth quarter 2024 financial results on Thursday, February 27, 2025, after the market [...]
Tevogen Bio CEO Congratulates Lynne Patton on Being Appointed Deputy Assistant to the President and Director of Minority Outreach
27/01/2025
WARREN, N.J., Jan. 27, 2025 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, Chairman and founding CEO of Tevogen Bio (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech, [...]
Oklahoma Arthritis Center Partners with Calvient to Transform Patient Care and Minimize Administrative Backlogs
27/01/2025
Improved No-Show Rate, Faster Referral Processing, and a 4.7/5 Google Rating Highlight Early Wins OKLAHOMA CITY, Jan. 27, 2025 (GLOBE NEWSWIRE) -- The Oklahoma Arthritis Center (OAC) today announced that its partnership [...]
Media Advisory/OHC - Ford government’s primary care announcement plays politics with people’s need for a family doctor: It’s a primary care “plan” to implement a plan delayed until the cusp of an election
27/01/2025
TORONTO, Jan. 27, 2025 (GLOBE NEWSWIRE) -- No matter how anyone tries to spin the numbers, the actual data from sources not tainted by politics, show that more than a million Ontarians have lost their family doctor [...]

Pages